Biotech 2050 Podcast

By Biotech 2050

Biotech 2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

  1. 1.
    61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences
    40:53
  2. 2.
    60. BIOS Edition: Investing in biotech and healthcare, Yizhen Dong, Partner, Global Founders Capital
    28:21
  3. 3.
    59. Targeted cancer therapies using engineered viruses, Alice Bexon, Chief Medical Officer, Vyriad
    19:20
  4. 4.
    58. End game vaccine for COVID-19, Marty Moore, Cofounder and CEO, Meissa Vaccines
    24:13
  5. 5.
    57. Next frontier in schizophrenia and mental health, Andrew Miller, Founder and COO, Karuna
    27:20
  6. 6.
    56. Turning cancer on itself, Sam Mazin, Founder and CTO, Thorsten Melcher, CBO, RefleXion
    27:49
  7. 7.
    55. Gene therapy for hearing loss, Heather Wolff, VP of Clinical Development Operations, Decibel
    21:41
  8. 8.
    54. CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
    22:15
  1. 9.
    53. Leading a rare disease biopharma company, Paula Ragan, CEO and President, X4 Pharmaceuticals
    27:10
  2. 10.
    52. SPACs and infectious disease past and future, Joe Hernandez, CEO, Blue Water Acquisition Corp.
    22:26
  3. 11.
    51. Pioneering innovations for neurological indications, Chris Wright, CMO, Cyclerion
    27:06
  4. 12.
    50. Noninvasive diagnostics for NASH and inflammatory indications, Caroline Loew, CEO, Glympse Bio
    27:47
  5. 13.
    49. Restoring connections for neurodegenerative diseases, Leen Kawas, CEO, Athira Pharma
    18:43
  6. 14.
    48. Anti-TNF: From Arthritis to Dementia and Fibrosis, Jim Woody, CEO, 180 Life Sciences
    22:53
  7. 15.
    47. Next generation cell-free cancer and autoimmune therapeutics, Bill Newell, CEO, Sutro Biopharma
    31:57
  8. 16.
    46. Fighting cancer with protein degradation, Adam Crystal, CMO, Stew Fisher, CSO, C4 Therapeutics
    33:45
  9. 17.
    45. Next generation of cell therapy, Brian Culley, CEO, Lineage Cell Therapeutics
    27:42
  10. 18.
    44. Revolutionizing the drug discovery marketplace, Kevin Lustig, Founder and CEO, Scientist.com
    23:44
  11. 19.
    43. From health economics to COVID19 treatment, Jonathan Javitt, Co-Founder and CEO, NeuroRx Pharma
    33:32
  12. 20.
    42. Combating COVID19, Mei Mei Hu, Co-Founder and CEO, and Peter Diamandis, Co-Founder, COVAXX
    24:41
  13. 21.
    41. Tackling the mental health pandemic, Shawn Singh, CEO, VistaGen Therapeutics
    19:21
  14. 22.
    40. Approaches to immunology, inflammation, and oncology, Dr. Luisa Salter-Cid, CSO, Gossamer Bio
    29:12
  15. 23.
    39. Biotech2050 Season 1 Wrap Up: Co-Hosts, Alok Tayi and Rahul Chaturvedi
    10:37
  16. 24.
    38. AI-driven early detection cancer screening from a blood test, Ken Chahine, CEO, Helio Health
    22:24
  17. 25.
    37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma
    23:35
  18. 26.
    36. Harnessing the innate immune system to combat disease, RJ Tesi, CEO and CMO, INmune Bio
    24:07
  19. 27.
    35. Continuous manufacturing in drug development, Matthew Bio, CEO, Snapdragon Chemistry
    27:11
  20. 28.
    34. Automation and Regenerative Manufacturing, Alexander Titus, Chief Strategy Officer, ARMI
    30:08
  21. 29.
    33. RNA modification gene therapy for rare disorders, Jim Burns, CEO, Kathie Bishop, CSO, Locanabio
    27:06
  22. 30.
    32. Vaccine origins to combat COVID-19, Seth Lederman, Co-Founder/CEO, Tonix Pharmaceuticals
    18:02
  23. 31.
    31. Drug discovery for neurodegenerative diseases, Victor Hanson-Smith, Comp. Bio., Verge Genomics
    21:02
  24. 32.
    30. Genetics and synthetic biology for trailblazing drug discovery, Maria Soloveychik, CEO, SyntheX
    17:46
  25. 33.
    29. Breakthrough imaging device for noninvasive cancer detection: Bob Proulx, CEO Imagion Biosystems
    25:21
  26. 34.
    28. Urology medtech for BPH with insights on patient care, VC, and more Nick Damiano, CEO, Zenflow
    21:56
  27. 35.
    27. Harnessing the microbiome to combat type 2 diabetes: Colleen Cutcliffe, CEO, Pendulum
    18:30
  28. 36.
    26. DNA testing to proactively inform treatment: Paul Billings, CMO, Natera
    35:43
  29. 37.
    25. The power of AI for precision drug discovery and development: Auransa Inc., Andy Protter, CSO
    20:53
  30. 38.
    24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOne
    21:00
  31. 39.
    23. Abbas Kazimi, VP of Business Development, Nimbus Therapeutics
    31:35
  32. 40.
    22. Randy Schatzman, Ph.D.,CEO and Board Member, Bolt Biotherapeutics
    20:11
  33. 41.
    21. Glenn Rosen, MD, Senior VP, Pre-Clinical Translational Sciences, Coherus BioSciences
    33:29
  34. 42.
    20. Diego Ardigò, MD, PhD, Head of Research and Development, Global Rare Diseases, Chiesi Group
    22:41
  35. 43.
    19. Mike Clayman, MD, CEO and Co-Founder, Flexion Therapeutics
    25:24
  36. 44.
    18. Grace Colón, PhD, President and CEO, InCarda Therapeutics
    22:49
  37. 45.
    17. Sachin Chandran, PhD, Exec. Dir., Head of Pharmaceutical Sciences, Catabasis Pharmaceuticals
    23:04
  38. 46.
    16. Mike Novotny, Founder and CEO, Medrio
    34:32
  39. 47.
    15. David Mace, Co-Founder and CEO, SwiftScale Biologics
    29:23
  40. 48.
    14. David Bates, PhD, Co-Founder, Linus Health
    34:45
  41. 49.
    13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion
    31:34
  42. 50.
    12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics
    33:25

Listen to Biotech 2050 Podcast now.

Listen to Biotech 2050 Podcast in full in the Spotify app